|
|
|
Volumn 8, Issue 1, 1998, Pages 157-182
|
|
Isolated lung perfusion with antineoplastic agents for pulmonary metastases
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 METHYLCHOLANTHRENE;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CHLORMETHINE;
CISPLATIN;
DOXORUBICIN;
FLOXURIDINE;
FLUOROURACIL;
GAMMA INTERFERON;
MELPHALAN;
MESSENGER RNA;
TUMOR NECROSIS FACTOR ALPHA;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG TISSUE LEVEL;
GENE TRANSFER;
HUMAN;
HYPERTHERMIC THERAPY;
INTRAARTERIAL DRUG ADMINISTRATION;
LUNG CIRCULATION;
LUNG FUNCTION TEST;
LUNG METASTASIS;
LUNG PERFUSION;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTE COUNT;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CARBOPLATIN;
CAUSE OF DEATH;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
CISPLATIN;
DOXORUBICIN;
FLOXURIDINE;
HUMANS;
HYPERTHERMIA, INDUCED;
LUNG NEOPLASMS;
PULMONARY ARTERY;
SURVIVAL RATE;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0031887857
PISSN: 10523359
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (67)
|
